[ Home ] [ Controlled Substances ] [ Stimulants ]
NEA
|
Etilamfetamine (Apetinil) is a stimulant drug of amphetamine chemical class. It is an N-substituted amphetamine with an ethyl group on the amphetamine backbone. It was used as an anorectic or appetite suppressant. Etilamfetamine is a psychoactive drug, which can be used as a recreational drug. Etilamfetamine has been abused as a "designer drug" alternative to amphetamine and possibly methamphetamine. It is a dopamine releasing agent.
Etilamfetamine (Apetinil):
https://drugs.ncats.io/drug/022YON1XMX
https://www.caymanchem.com/msdss/11557m.pdf
It was invented in the early 20th century and was subsequently used as an anorectic or appetite suppressant in the 1950s, but was not as commonly used as other amphetamines. was largely discontinued once newer drugs such as phenmetrazine were introduced. It most likely acts primarily as a dopamine releasing agent. Its activity as a norepinephrine or serotonin releasing agent is not known. Ethylamphetamine can be used as a recreational drug and, while its prevalence is less than amphetamine's, it is still encountered as a substance taken for recreational purposes. Ethylamphetamine produces effects similar to amphetamine and methamphetamine, though its potency is less. At equipotent dosage, ethylamphetamine is subjectively less euphorigenic.
State police to participate in NEA drug take-back - The Drug Enforcement Administration (DEA) is sponsoring the 27th nationwide “Prescription Drug Take Back” initiative on Saturday. The “Take Back” initiative seeks to prevent prescription ... Wednesday October 23, 2024 - therepublic.com NEA Venture Partner Scott Gottlieb, M.D., Nominated To Be Commissioner ... - CHEVY CHASE, Md., March 11, 2017 /PRNewswire/ -- New Enterprise Associates, Inc. (NEA) Venture Partner Scott Gottlieb, M.D., has been nominated by President Donald J. Trump to serve as ... Cydan, a New Orphan Drug Accelerator, Launches with $16 Million ... - Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors NEA, Pfizer Venture Investments and Alexandria Real E ... NEA leads $16M round for drug-eluting balloon firm - CV Ingenuity has inflated its coffers with a fresh round of venture cash amid development of its drug-eluting balloon technology. The Palo Alto, CA-based medical devices firm has raised $16 million ... NEA leads $16m investment in orphan drug accelerator - NEA is one of the only prolific biotech funders based in the D.C. region. Also this week, it invested $10 million in California cancer drug developer Cleave Biosciences. NEA Hires Drug-Development Expert Elliott Sigal as Venture Partner - He brings to NEA more than 25 years of experience spanning drug discovery, drug development, corporate strategy and general management, the venture firm said in a news release. NEA's Jim Barrett: Drug innovation should be rewarded - Barrett’s assertion is an important one, because — at the very least — it explains some of NEA’s thinking on how it funds the life sciences, including in its home turf of Montgomery County. Major drug bust nets 18 arrests in NEA - victoriaadvocate.com - The drug operation, according to a federal indictment, was allegedly led by Jack Brown, 58, of Marked Tree; Reginald Hendrix, 53, of Trumann; and Dewayne Morris, 36, of Trumann. NEA Backs Startup’s Software to Assess Drug Performance - NEA Backs Startup’s Software to Assess Drug Performance General Partner Mohamad Makhzoumi joins board of Aetion By Heather Mack April 11, 2018 6:00 am ET | WSJ Pro ... Cydan, a New Orphan Drug Accelerator, Launches with $16 Million ... - Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors NEA, Pfizer Venture Investments and Alexandria Real Estate Equities Cambridge, Mass. – April 11, ... NEA Venture Partner Scott Gottlieb, M.D., Nominated To Be ... - Medindia - New Enterprise Associates , Inc. (NEA) Venture Partner Scott Gottlieb, M.D., has been nominated by President Donald J. Trump to serve as Commissioner of the U.S. Food and Drug ...
| ||
| Stimulants | Link to this page |